GIVING . CONTACT . SEARCH . HOME . EMORY



Overview
Press Releases
Video News Releases
Multimedia
Publications
General Media Information
Photography Services
Communications Staff
Public Events
Emory in the News
Press Kits
Honors and Awards
Expert List




Media Contact: Holly Korschun 03 May 2007
  hkorsch@emory.edu    
  (404) 727-3990   Print  | Email ]
Share:

del.icio.us

Action Cycling 200 Bike Race, May 19-20, Raises Funds for AIDS Vaccine Research
Cycling enthusiasts are invited to help create a world without AIDS by pedaling for a purpose May 19-20 to raise money for AIDS vaccine research at the Emory Vaccine Center. This year's two-day Action Cycling 200 bike ride marks the AC200's fifth year, with 100 percent of the money raised -- $240,000 thus far -- going directly to HIV/AIDS vaccine research.

Action Cycling Atlanta is a local cycling group whose members have participated in many national and international bike rides benefiting AIDS vaccine research. Bike riders raise money to participate in the event as individuals, relay team riders or crew members. Ride sponsors include CUH2A, Emory Healthcare, Emory Conference Center and Hotel, Urban Body Fitness, Southern Company, The Coca-Cola Company, AutoTrader.com, Sodexho USA, Perkins+Will, Noel Axton and Associates, and Outback Bikes.

"Our research at the Emory Vaccine Center has resulted in one of the leading AIDS vaccines currently in clinical trials, as well as other highly promising AIDS vaccine approaches," says Vaccine Center Director Rafi Ahmed. "Support from Action Cycling Atlanta and the riders this weekend will help us to continue pursuing this critical research, and we are honored to have their sponsorship this year and in years past. The ACS funds help fill critical gaps in our federal grant funding and provide seed funding for innovative pilot projects."

Riders will depart at 7:00 a.m. Saturday, May 19 from the old train depot on Asbury Circle (across from Means Hall) on the Emory campus and stay overnight at Rock Eagle 4-H Center before returning to the same depot Sunday, May 20 for a celebration barbeque from 5 p.m. to 7 p.m.

Emory Vaccine Center scientists are developing vaccines for HIV/AIDS, hepatitis C, malaria, influenza and other global disease threats. An AIDS vaccine developed at the Emory Vaccine Center, Yerkes National Primate Research Center, the National Institutes of Health and GeoVax Labs, Inc., currently is being tested in clinical trials at several national sites. The Vaccine Center's Hope Clinic conducts clinical trials of vaccines being developed for AIDS and other diseases.

To learn more about the Action Cycling 200 ride or to register, volunteer, or make a pledge, visit http://www.actioncycling.org For more information about the Emory Vaccine Center, visit http://www.vaccines.emory.edu.



<<::Back to Press Releases








About Us | Education | Patient Care | Research | News & Publications Site Map  






Copyright © Emory University, 2018. All Rights Reserved.